Skip to content

Risk Reduction Intervention for Vulnerable Young Adult Males

Risk Reduction Intervention for Vulnerable Young Adult Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01118416
Acronym
YMHP
Enrollment
317
Registered
2010-05-06
Start date
2006-06-30
Completion date
2011-10-31
Last updated
2013-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV, Sex, Substance Use

Keywords

sexual risk, substance use, HIV, prevention, intervention, Motivational Enhancement Therapy, young men who have sex with men

Brief summary

The primary aim of this study is to test a brief 4-session risk reduction intervention, based on Motivational Enhancement Therapy (MET) to reduce the co-occurrence of club drug use and sexual risk taking behaviors among non-treatment seeking young men who have sex with men (YMSM) in NYC.

Detailed description

This study is a randomized clinical trial. A sample of 300 non-treatment seeking YMSM (ages 18-24) who report risky sex and club drug use in the past 90 days are being enrolled using active and passive community-based recruitment strategies in NYC. After baseline assessment, participants are being randomly assigned to one of two study arms: a Brief Risk Reduction Intervention Condition - a four session MET intervention piloted for feasibility and acceptability among YMSM, designed to increase readiness to change club drug use and unprotected sex; or an Education Comparison Condition - four sessions of facilitated education regarding the effects of club drugs and unprotected sex. Participants undergo follow-up assessments 3, 6, 9, and 12 months after baseline.

Interventions

BEHAVIORALHIV prevention intervention randomized control trial

Substance using HIV-negative young MSM who engage in sexual risk are randomized to either a motivational interviewing or an education condition to reduce sexual risk and drug use.

Sponsors

Hunter College of City University of New York
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 29 Years
Healthy volunteers
Yes

Inclusion criteria

* At least 5 days of drug use (cocaine, ketamine, ecstasy, methamphetamine, or GHB) in the past 90 days; * At least 1 instance of unprotected anal sex in the past 90 days; * Biological male; * HIV-negative; * Residential stability; * Ability to communicate in written English.

Exclusion criteria

* Unstable, serious psychiatric symptoms; * Currently suicidal/homicidal; * Evidence of gross cognitive impairment; * Reports current enrollment in a drug or HIV related intervention or research study.

Design outcomes

Primary

MeasureTime frameDescription
Sexual riskevery three months over the course of a yearParticipants in the MET condition will report greater reductions in the number of unprotected anal intercourse acts and in the proportion of days of club drug use than those in the education comparison condition at the end of the intervention period (3 months) and will maintain greater reductions in the number of unprotected anal intercourse acts and the proportion of days of club drug use than those in the education comparison condition at the three follow-up assessments (6, 9, and 12 months).

Secondary

MeasureTime frameDescription
motivation to change club drug use and unsafe sex over 12 monthsevery three months over the course of a yearThe following factors assessed at baseline will predict club drug use and unsafe sex over the 12-month outcome period: baseline severity of club drug use, baseline severity of other substance use, motivation, decisional balance, and self-efficacy.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026